T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment
T细胞谱分析显示,高CD4+CTLA-4+T细胞频率是前列腺癌GVAX/ipilimumab治疗后生存的主要预测因子。
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-012-1330-5
Santegoets, Saskia J A M; Stam, Anita G M; Lougheed, Sinéad M; Gall, Helen; Scholten, Petra E T; Reijm, Martine; Jooss, Karin; Sacks, Natalie; Hege, Kristen; Lowy, Israel; Cuillerot, Jean-Marie; von Blomberg, B Mary E; Scheper, Rik J; van den Eertwegh, Alfons J M; Gerritsen, Winald R; de Gruijl, Tanja D
肿瘤
T细胞
肿瘤免疫
T细胞
细胞生物学
前列腺癌
CD4
免疫/内分泌